1. Home
  2. MRKR vs BWEN Comparison

MRKR vs BWEN Comparison

Compare MRKR & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • BWEN
  • Stock Information
  • Founded
  • MRKR N/A
  • BWEN N/A
  • Country
  • MRKR United States
  • BWEN United States
  • Employees
  • MRKR N/A
  • BWEN N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • MRKR Health Care
  • BWEN Industrials
  • Exchange
  • MRKR Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • MRKR 35.8M
  • BWEN 40.1M
  • IPO Year
  • MRKR N/A
  • BWEN N/A
  • Fundamental
  • Price
  • MRKR $3.50
  • BWEN $1.62
  • Analyst Decision
  • MRKR Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • MRKR 1
  • BWEN 3
  • Target Price
  • MRKR $19.00
  • BWEN $5.17
  • AVG Volume (30 Days)
  • MRKR 34.9K
  • BWEN 230.0K
  • Earning Date
  • MRKR 11-22-2024
  • BWEN 11-13-2024
  • Dividend Yield
  • MRKR N/A
  • BWEN N/A
  • EPS Growth
  • MRKR N/A
  • BWEN N/A
  • EPS
  • MRKR N/A
  • BWEN 0.14
  • Revenue
  • MRKR $3,727,435.00
  • BWEN $156,169,000.00
  • Revenue This Year
  • MRKR $35.94
  • BWEN N/A
  • Revenue Next Year
  • MRKR N/A
  • BWEN $24.98
  • P/E Ratio
  • MRKR N/A
  • BWEN $11.56
  • Revenue Growth
  • MRKR N/A
  • BWEN N/A
  • 52 Week Low
  • MRKR $2.44
  • BWEN $1.52
  • 52 Week High
  • MRKR $6.16
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 46.47
  • BWEN 30.85
  • Support Level
  • MRKR $3.52
  • BWEN $1.82
  • Resistance Level
  • MRKR $3.90
  • BWEN $1.98
  • Average True Range (ATR)
  • MRKR 0.40
  • BWEN 0.12
  • MACD
  • MRKR -0.08
  • BWEN -0.03
  • Stochastic Oscillator
  • MRKR 0.00
  • BWEN 18.97

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.

Share on Social Networks: